Table 3. Multivariable Regression for All-Cause Mortality by Age Group and for Coronary Heart Disease (CHD) Events by Age Group.

Variable	65-74 y		≥75 y		Total
	HR (95% CI)	P Value	HR (95% CI)	P Value	HR (95% CI)	P Value
Multivariable Regression for All-Cause Mortality by Age Group
Pravastatin	1.05 (0.82-1.33)	.72	1.36 (0.98-1.89)	.06	1.15 (0.94-1.39)	.17
Age	1.06 (1.01-1.10)	.01	1.11 (1.06-1.15)	<.01	1.08 (1.06-1.10)	<.01
Female	0.83 (0.65-1.07)	.16	0.53 (0.38-0.74)	<.01	0.71 (0.58-0.87)	<.01
Systolic blood pressure	1.01 (1.00-1.02)	.01	1.01 (1.00-1.02)	.11	1.01 (1.00-1.02)	<.01
Diastolic blood pressure	0.99 (0.98-1.01)	.37	1.00 (0.98-1.02)	.90	1.00 (0.99-1.01)	.52
Aspirin use	1.03 (0.77-1.36)	.86	0.86 (0.59-1.24)	.42	0.97 (0.77-1.21)	.78
Body mass index	1.00 (0.98-1.02)	.90	0.99 (0.95-1.02)	.44	1.00 (0.98-1.02)	.98
Black race/ethnicity	1.04 (0.81-1.33)	.76	1.15 (0.82-1.60)	.41	1.08 (0.88-1.31)	.47
Current cigarette smoker	1.90 (1.43-2.53)	<.01	1.49 (0.91-2.45)	.11	1.75 (1.37-2.24)	<.01
Type 2 diabetes	1.74 (1.32-2.29)	<.01	1.66 (1.17-2.35)	<.01	1.66 (1.34-2.05)	<.01
Multivariable Regression for CHD Events by Age Group
Pravastatin	0.85 (0.63-1.16)	.31	0.70 (0.42-1.15)	.16	0.80 (0.62-1.04)	.09
Age	1.02 (0.96-1.08)	.48	1.05 (0.99-1.12)	.13	1.03 (1.01-1.06)	.01
Female	0.77 (0.56-1.06)	.11	0.46 (0.27-0.77)	<.01	0.65 (0.50-0.86)	<.01
Systolic blood pressure	1.01 (1.00-1.02)	.06	1.01 (0.99-1.02)	.51	1.01 (1.00-1.02)	.06
Diastolic blood pressure	1.00 (0.98-1.02)	.75	1.00 (0.98-1.03)	.86	1.00 (0.98-1.01)	.83
Aspirin use	1.05 (0.73-1.49)	.80	1.52 (0.92-2.51)	.11	1.21 (0.91-1.61)	.20
Body mass index	1.00 (0.97-1.02)	.75	0.95 (0.90-1.01)	.10	0.99 (0.96-1.01)	.29
Black race/ethnicity	0.93 (0.68-1.28)	.66	0.79 (0.46-1.35)	.39	0.89 (0.68-1.17)	.40
Current cigarette smoker	1.49 (1.02-2.17)	.04	0.95 (0.41-2.16)	.89	1.31 (0.93-1.84)	.13
Type 2 diabetes	2.13 (1.49-3.04)	<.01	1.30 (0.78-2.18)	.32	1.80 (1.35-2.40)	<.01

Abbreviation: HR, hazard ratio for pravastatin sodium vs usual care.